Burrows Scott L Insider Trades

Insider Trading History

Track insider trading activity for Burrows Scott L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $9.87M 99,719 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$658k 7,500 shares
$87.74
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $34.9M 352,357 shares
Last Trade
Jul 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$667k 7,500 shares
$88.89
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $10.4M 105,494 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$667k 7,500 shares
$88.89
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $35.6M 359,857 shares
Last Trade
Jun 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.33M 15,000 shares
$88.67
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $11.2M 112,994 shares
Last Trade
Jun 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.33M 15,000 shares
$88.67
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $10.7M 107,994 shares
Last Trade
Jun 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.31M 15,000 shares
$87.13
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $10.3M 103,693 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$533k 7,500 shares
$71.06
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $37.1M 374,857 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$529k 7,500 shares
$70.54
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $10.4M 105,494 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$529k 7,500 shares
$70.54
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $10.9M 110,494 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$868k 12,500 shares
$69.42
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $9.7M 97,994 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$892k 12,500 shares
$71.37
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $37.8M 382,357 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$868k 12,500 shares
$69.42
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $10.4M 105,494 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$367k 7,500 shares
$48.90
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $39.1M 394,857 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$367k 7,500 shares
$48.90
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $9.83M 99,294 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$370k 7,500 shares
$49.34
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $9.72M 98,194 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$102k 2,500 shares
$40.65
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $9.94M 100,494 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$100k 2,500 shares
$40.07
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $39.8M 402,357 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$100k 2,500 shares
$40.07
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $13.9M 140,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.29M 140,000 shares
$30.61
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $9.7M 97,994 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$300k 18,428 shares
$16.26
$98.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up